AI assistant
MEDIFAST INC — Director's Dealing 2024
Mar 12, 2024
33899_dirs_2024-03-12_c77310e6-ff88-4074-818d-0688dff8adbf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2024-03-08
Reporting Person: SCHLACKMAN SCOTT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-08 | Common Stock | M | 1300 | $27.68 | Acquired | 11837.707 | Direct |
| 2024-03-08 | Common Stock | S | 1300 | $39.41 | Disposed | 10537.707 | Direct |
| 2024-03-08 | Common Stock | S | 2753 | $39.46 | Disposed | 7784.707 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-08 | Stock Option (Right to Buy) | $27.68 | M | 1300 | Disposed | 2026-02-04 | Common Stock (1300) | Direct |
Footnotes
F1: The price reported in Column 4 is an average price. These shares were acquired in multiple transactions at prices ranging from $39.38 to $39.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
F2: The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.